Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects of these treatments include osteoporosis,

Niagara men's basketball kicked off Suits and Sneakers week, in which college basketball coaches wear suits and sneakers on the sidelines and programs across the nation raise money for cancer research and awareness.

According to the World Health Organization (WHO), in 2022, there were 2.3 million women diagnosed with breast cancer and 670 000 deaths globally.

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or metastatic hormone receptor HR+, HER2- breast cancer in adult patients who have previously received endocrine-based therapy and chemotherapy for unresectable or metastatic disease, according to a news release.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.

A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast Recurrence Score® result provides more accurate estimates about that patient’s breast cancer prognosis and their potential benefit from chemotherapy than either the Recurrence Score result or clinical factors alone.

Breast cancer remains the number one diagnosed cancer in women in the United States, other than skin cancer, according to the American Society of Clinical Oncology (ASCO). If you're concerned about breast cancer affecting you or someone close to you, this ...

Researchers sought to determine the effect of changes in screening guidelines on incidence of breast cancer by stage at diagnosis and surgical management.

Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community Church.

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including colorectal and prostate cancers.

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and testing for inherited genetic mutations linked with increased cancer risk.